Palatin Technologies, Inc.
Licensing agreement extended for European marketing rights to infection agent
Published in Telemedicine Week, July 12th, 2005
The original agreement granted Mallinckrodt an exclusive license to market and distribute NeutroSpec worldwide, excluding Europe. Under the terms of the amendment, Mallinckrodt and Palatin will jointly develop and commercialize NeutroSpec for all global markets. Tyco and Palatin are working to develop an international regulatory strategy. Financial terms of the amended agreement were not disclosed.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week
Source: Telemedicine Week (2005-07-12)
More Articles from Telemedicine Week
- Bristol-Myers Squibb
Abatacept inhibits progression of joint damage in rheumatoid arthritis - Inst. of Biomedical Research & Innovation, Hyogo
Accuracy of image fusion using fixation device for cancer imaging was evaluated - Medical University of Vienna
3D-conformal radiotherapy may prevent in-stent restenosis - Nonlinear Dynamics, Ltd.
APAF purchases Progenesis Discovery for gel imaging - Abbott
Humira and methotrexate may affect disease progression - Advanced Chemistry Development, Inc.
Public chromatography applications database updated - More from this issue of Telemedicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
